- Home
- IRON vs PAX Comparison
IRON vs PAX Comparison
Compare IRON & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- PAX
- Stock Information
- Founded
- IRON 2017
- PAX 1988
- Country
- IRON United States
- PAX Cayman Islands
- Employees
- IRON N/A
- PAX N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- PAX Investment Managers
- Sector
- IRON Health Care
- PAX Finance
- Exchange
- IRON Nasdaq
- PAX Nasdaq
- Market Cap
- IRON 1.9B
- PAX 1.8B
- IPO Year
- IRON N/A
- PAX 2021
- Fundamental
- Price
- IRON $58.25
- PAX $11.65
- Analyst Decision
- IRON Strong Buy
- PAX Strong Buy
- Analyst Count
- IRON 10
- PAX 1
- Target Price
- IRON $73.70
- PAX $14.00
- AVG Volume (30 Days)
- IRON 267.1K
- PAX 590.4K
- Earning Date
- IRON 11-12-2024
- PAX 02-13-2025
- Dividend Yield
- IRON N/A
- PAX 5.15%
- EPS Growth
- IRON N/A
- PAX N/A
- EPS
- IRON N/A
- PAX 0.42
- Revenue
- IRON N/A
- PAX $328,717,000.00
- Revenue This Year
- IRON N/A
- PAX $2.35
- Revenue Next Year
- IRON N/A
- PAX $26.31
- P/E Ratio
- IRON N/A
- PAX $27.62
- Revenue Growth
- IRON N/A
- PAX 7.39
- 52 Week Low
- IRON $25.60
- PAX $10.63
- 52 Week High
- IRON $77.60
- PAX $16.16
- Technical
- Relative Strength Index (RSI)
- IRON 40.61
- PAX 50.49
- Support Level
- IRON $57.09
- PAX $11.10
- Resistance Level
- IRON $61.08
- PAX $11.62
- Average True Range (ATR)
- IRON 2.83
- PAX 0.30
- MACD
- IRON -0.58
- PAX 0.01
- Stochastic Oscillator
- IRON 14.04
- PAX 74.36
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About PAX Patria Investments Limited
Patria Investments Ltd is a private markets investment firm. It seeks to provide global and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns.